Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 8 | 2018 | 68 | 1.740 |
Why?
|
| Electric Stimulation Therapy | 5 | 2017 | 39 | 1.230 |
Why?
|
| Anticonvulsants | 5 | 2006 | 52 | 0.770 |
Why?
|
| Epilepsy, Temporal Lobe | 3 | 2017 | 29 | 0.510 |
Why?
|
| Electroencephalography | 4 | 2017 | 78 | 0.510 |
Why?
|
| Epilepsies, Partial | 4 | 2017 | 12 | 0.470 |
Why?
|
| Implantable Neurostimulators | 2 | 2014 | 8 | 0.440 |
Why?
|
| Valproic Acid | 2 | 2004 | 14 | 0.420 |
Why?
|
| Pharmaceutical Services | 1 | 2013 | 2 | 0.410 |
Why?
|
| Pharmacists | 1 | 2013 | 16 | 0.400 |
Why?
|
| Dyslipidemias | 1 | 2013 | 15 | 0.400 |
Why?
|
| Hypolipidemic Agents | 1 | 2013 | 22 | 0.400 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2010 | 24 | 0.330 |
Why?
|
| Brain Mapping | 3 | 2017 | 123 | 0.280 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2017 | 11 | 0.260 |
Why?
|
| Deep Brain Stimulation | 2 | 2017 | 40 | 0.260 |
Why?
|
| Developmental Disabilities | 1 | 2006 | 24 | 0.250 |
Why?
|
| Humans | 18 | 2023 | 23331 | 0.230 |
Why?
|
| Magnetoencephalography | 1 | 2004 | 2 | 0.210 |
Why?
|
| Landau-Kleffner Syndrome | 1 | 2003 | 1 | 0.210 |
Why?
|
| Functional Laterality | 1 | 2004 | 56 | 0.210 |
Why?
|
| Brain | 2 | 2017 | 1200 | 0.200 |
Why?
|
| Vascular System Injuries | 1 | 2023 | 4 | 0.200 |
Why?
|
| Angiography | 1 | 2023 | 25 | 0.200 |
Why?
|
| Sleep | 1 | 2003 | 268 | 0.180 |
Why?
|
| Follow-Up Studies | 5 | 2018 | 1441 | 0.170 |
Why?
|
| Treatment Outcome | 6 | 2023 | 2988 | 0.160 |
Why?
|
| Intellectual Disability | 2 | 2013 | 43 | 0.160 |
Why?
|
| Adolescent | 6 | 2017 | 1916 | 0.160 |
Why?
|
| Child, Preschool | 4 | 2008 | 578 | 0.160 |
Why?
|
| Child | 4 | 2008 | 1171 | 0.150 |
Why?
|
| Feasibility Studies | 3 | 2017 | 210 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 43 | 0.140 |
Why?
|
| Female | 9 | 2018 | 13124 | 0.140 |
Why?
|
| Cerebral Cortex | 2 | 2017 | 127 | 0.140 |
Why?
|
| Male | 10 | 2018 | 12629 | 0.140 |
Why?
|
| Neocortex | 1 | 2017 | 22 | 0.130 |
Why?
|
| Middle Aged | 7 | 2018 | 8055 | 0.130 |
Why?
|
| Young Adult | 4 | 2017 | 1674 | 0.120 |
Why?
|
| Cohort Studies | 3 | 2018 | 1429 | 0.120 |
Why?
|
| Delayed-Action Preparations | 2 | 2004 | 28 | 0.110 |
Why?
|
| Time Factors | 3 | 2014 | 1289 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2023 | 3040 | 0.110 |
Why?
|
| Spasms, Infantile | 1 | 2013 | 1 | 0.100 |
Why?
|
| Hospitals, Veterans | 1 | 2013 | 6 | 0.100 |
Why?
|
| Professional Role | 1 | 2013 | 28 | 0.100 |
Why?
|
| Lipids | 1 | 2013 | 45 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2013 | 220 | 0.100 |
Why?
|
| Aged | 4 | 2018 | 7552 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 289 | 0.090 |
Why?
|
| Primary Health Care | 1 | 2013 | 76 | 0.090 |
Why?
|
| Mutation | 1 | 2013 | 328 | 0.090 |
Why?
|
| Veterans | 1 | 2013 | 87 | 0.090 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2010 | 48 | 0.080 |
Why?
|
| Adult | 6 | 2017 | 7070 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 442 | 0.080 |
Why?
|
| Electrodiagnosis | 1 | 2008 | 6 | 0.070 |
Why?
|
| Epidural Space | 1 | 2008 | 20 | 0.070 |
Why?
|
| Monitoring, Physiologic | 1 | 2008 | 68 | 0.070 |
Why?
|
| Preoperative Care | 1 | 2008 | 112 | 0.070 |
Why?
|
| Electrodes, Implanted | 2 | 2017 | 22 | 0.070 |
Why?
|
| Isoxazoles | 1 | 2005 | 5 | 0.060 |
Why?
|
| Kidney Calculi | 1 | 2005 | 6 | 0.060 |
Why?
|
| Ureteral Calculi | 1 | 2005 | 6 | 0.060 |
Why?
|
| Incidence | 1 | 2006 | 636 | 0.060 |
Why?
|
| Corpus Callosum | 1 | 2004 | 11 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2004 | 55 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 197 | 0.050 |
Why?
|
| Temporal Lobe | 1 | 2004 | 63 | 0.050 |
Why?
|
| Extremities | 1 | 2023 | 24 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 1 | 2023 | 23 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2023 | 33 | 0.050 |
Why?
|
| Drug Hypersensitivity | 1 | 2003 | 6 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2003 | 29 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 322 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 324 | 0.050 |
Why?
|
| Prognosis | 1 | 2003 | 740 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 880 | 0.040 |
Why?
|
| Seizures | 1 | 2018 | 67 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2018 | 102 | 0.030 |
Why?
|
| Epilepsy, Partial, Motor | 1 | 2017 | 1 | 0.030 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2017 | 4 | 0.030 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2017 | 5 | 0.030 |
Why?
|
| Dominance, Cerebral | 1 | 2017 | 15 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2017 | 56 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 3783 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 641 | 0.030 |
Why?
|
| Lennox Gastaut Syndrome | 1 | 2013 | 1 | 0.030 |
Why?
|
| Mutation Rate | 1 | 2013 | 3 | 0.030 |
Why?
|
| Receptors, GABA-A | 1 | 2013 | 2 | 0.030 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2013 | 2 | 0.030 |
Why?
|
| Exome | 1 | 2013 | 4 | 0.030 |
Why?
|
| Probability | 1 | 2013 | 73 | 0.030 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 16 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 382 | 0.020 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2013 | 110 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 262 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 486 | 0.020 |
Why?
|
| Quality of Life | 1 | 2014 | 560 | 0.020 |
Why?
|
| Electrodes | 1 | 2008 | 14 | 0.020 |
Why?
|
| Craniotomy | 1 | 2008 | 21 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2008 | 59 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2008 | 140 | 0.020 |
Why?
|
| Calcium Citrate | 1 | 2005 | 1 | 0.010 |
Why?
|
| Carbamazepine | 1 | 2005 | 4 | 0.010 |
Why?
|
| Piracetam | 1 | 2005 | 7 | 0.010 |
Why?
|
| Fluid Therapy | 1 | 2005 | 25 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 161 | 0.010 |
Why?
|
| Recurrence | 1 | 2005 | 272 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2005 | 204 | 0.010 |
Why?
|